1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Adenocarcinoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| d'Argy, R; Gunnarsson, PO; Johansson, CJ; Lundin, N; Teder, H | 1 |
| Bibby, MC; Cox, JA; Crawford, SM; Quinn, PK | 1 |
| al-Ghabban, AF; Bibby, MC; Double, JA; Loadman, PM | 1 |
| Bach, F; Dombernowsky, P; Hansen, HH; Sørensen, JB; Vibe-Petersen, J | 2 |
| Bach, F; Hansen, HH; Pedersen, AG; Smyth, J; Vibe-Petersen, J | 1 |
| Atassi, G; Dumont, P; Fournier, JP; Gosse, C; Gouyette, A; Roger, P | 1 |
| Bruntsch, U; Cavalli, F; Dombernowsky, P; Gundersen, S; Pinedo, H; Renard, J; Van Glabbeke, M | 1 |
| Bibby, MC; Bloomer, JC; Double, JA; Loadman, PM | 1 |
| Bibby, MC; Double, JA; Morris, CM | 1 |
| Hansen, M; Heaf, JG | 1 |
11 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Adenocarcinoma
| Article | Year |
|---|---|
The effect of different dose levels of degradable starch microspheres (Spherex) on the distribution of a cytotoxic drug after regional administration to tumour-bearing rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carbon Radioisotopes; Colonic Neoplasms; Injections, Intra-Arterial; Injections, Intravenous; Male; Microspheres; Neoplasm Transplantation; Nitrosourea Compounds; Rats; Rats, Wistar; Taurine; Time Factors; Tissue Distribution | 1995 |
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.
Topics: Adenocarcinoma; Animals; Bone Marrow; Cell Division; Cell Line; Colonic Neoplasms; Hydralazine; Male; Melphalan; Mice; Mice, Inbred Strains; Nitrosourea Compounds; Radionuclide Imaging; Regional Blood Flow; Taurine; Tumor Stem Cell Assay | 1992 |
Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Synergism; Glomerular Filtration Rate; Half-Life; Hydralazine; Injections, Intravenous; Insulin; Kidney; Liver; Lung; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Nitrosourea Compounds; Taurine; Tissue Distribution | 1992 |
Phase II trial of TCNU and vindesine in patients with adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Remission Induction; Taurine; Vindesine | 1990 |
TCNU in adenocarcinoma of the lung: a phase II study with divided doses.
Topics: Adenocarcinoma; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Nitrosourea Compounds; Taurine | 1990 |
A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Taurine | 1989 |
Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Nitrosourea Compounds; Taurine; Time Factors | 1989 |
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Humans; Middle Aged; Nitrosourea Compounds; Taurine | 1989 |
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrations.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Colonic Neoplasms; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Neoplasm Transplantation; Nitrosourea Compounds; Taurine; Tissue Distribution | 1988 |
Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Neoplasm Transplantation; Nitrosourea Compounds; Taurine | 1988 |
Treatment of refractory cancer-associated hypercalcemia with aminohydroxypropylidene diphosphonate.
Topics: Adenocarcinoma; Antineoplastic Agents; Diphosphonates; Female; Humans; Hypercalcemia; Lung Neoplasms; Middle Aged; Nitrosourea Compounds; Pamidronate; Taurine | 1988 |